Fibroblast Growth Factor 23, Bone Mineral Density, and Risk of Hip Fracture Among Older Adults: The Cardiovascular Health Study

CONTEXT: Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that also inhibits calcitriol synthesis. OBJECTIVE: Our objective was to evaluate the relationships of plasma FGF23 concentrations with bone mineral density (BMD) and hip fracture in community-dwelling older adults. DESIGN AND SE...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Jovanovich, Anna, Bùžková, Petra, Chonchol, Michel, Robbins, John, Fink, Howard A., de Boer, Ian H., Kestenbaum, Bryan, Katz, Ronit, Carbone, Laura, Lee, Jennifer, Laughlin, Gail A., Mukamal, Kenneth J., Fried, Linda F., Shlipak, Michael G., Ix, Joachim H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2013
Pynciau:
Endocrine Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3733860/
https://ncbi.nlm.nih.gov/pubmed/23771921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-1152
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg